113 related articles for article (PubMed ID: 9876112)
1. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
Shinkai H; Ozeki H; Motomura T; Ohta T; Furukawa N; Uchida I
J Med Chem; 1998 Dec; 41(27):5420-8. PubMed ID: 9876112
[TBL] [Abstract][Full Text] [Related]
2. JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats.
Ohta T; Furukawa N; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Feb; 367(1):91-9. PubMed ID: 10082270
[TBL] [Abstract][Full Text] [Related]
3. Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound.
Furukawa N; Ohta T; Noguchi T; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Apr; 371(1):51-8. PubMed ID: 10355594
[TBL] [Abstract][Full Text] [Related]
4. Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.
Ohta T; Sasase T; Miyajima K; Matsui K; Matsushita M; Furukawa N; Yonemori F
Diabetes Obes Metab; 2005 Sep; 7(5):517-24. PubMed ID: 16050944
[TBL] [Abstract][Full Text] [Related]
5. JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
Ohta T; Furukawa N; Komuro G; Yonemori F; Wakitani K
Br J Pharmacol; 1999 Apr; 126(7):1674-80. PubMed ID: 10323602
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats.
Ohta T; Miyajima K; Komuro G; Furukawa N; Yonemori F
Eur J Pharmacol; 2003 Aug; 476(1-2):159-66. PubMed ID: 12969761
[TBL] [Abstract][Full Text] [Related]
7. The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.
Mukai E; Ishida H; Fujimoto S; Kajikawa M; Okamoto Y; Fujita J; Hamamoto Y; Tsuura Y; Yamada Y; Furukawa N; Ohta T; Seino Y
Br J Pharmacol; 2000 Mar; 129(5):901-8. PubMed ID: 10696088
[TBL] [Abstract][Full Text] [Related]
8. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1-[4- [2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro.
Wu GZ; Hong G; Zhang WP; Zhang HB
Arzneimittelforschung; 2009; 59(11):550-6. PubMed ID: 20066963
[TBL] [Abstract][Full Text] [Related]
10. Insulin-secretagogue activity of p-methoxycinnamic acid in rats, perfused rat pancreas and pancreatic beta-cell line.
Yibchok-anun S; Adisakwattana S; Moonsan P; Hsu WH
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):476-82. PubMed ID: 18346054
[TBL] [Abstract][Full Text] [Related]
11. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
[TBL] [Abstract][Full Text] [Related]
12. Lisofylline, a novel anti-inflammatory agent, enhances glucose-stimulated insulin secretion in vivo and in vitro: studies in prediabetic and normal rats.
Striffler JS; Nadler JL
Metabolism; 2004 Mar; 53(3):290-6. PubMed ID: 15015139
[TBL] [Abstract][Full Text] [Related]
13. The antidiabetic effect of Geigeria alata is mediated by enhanced insulin secretion, modulation of β-cell function, and improvement of antioxidant activity in streptozotocin-induced diabetic rats.
Hafizur RM; Babiker R; Yagi S; Chishti S; Kabir N; Choudhary MI
J Endocrinol; 2012 Sep; 214(3):329-35. PubMed ID: 22736483
[TBL] [Abstract][Full Text] [Related]
14. Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats.
Nakayama K; Murakami N; Ohta M; Kato K; Notsu T; Mizota M; Miwa I; Okuda J
Eur J Pharmacol; 1995 Mar; 276(1-2):85-91. PubMed ID: 7781699
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in streptozotocin (STZ)-induced diabetic rats.
Kalailingam P; Kannaian B; Tamilmani E; Kaliaperumal R
Phytomedicine; 2014 Sep; 21(10):1154-61. PubMed ID: 24889525
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel and potent GPR119 agonists with a spirocyclic structure.
Harada K; Mizukami J; Kadowaki S; Matsuda I; Watanabe T; Oe Y; Kodama Y; Aoki K; Suwa K; Fukuda S; Yata S; Inaba T
Bioorg Med Chem Lett; 2018 Apr; 28(7):1228-1233. PubMed ID: 29519733
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats.
Nayak Y; Hillemane V; Daroji VK; Jayashree BS; Unnikrishnan MK
ScientificWorldJournal; 2014; 2014():854267. PubMed ID: 25548795
[TBL] [Abstract][Full Text] [Related]
18. Effects of Orthosiphon stamineus aqueous extract on plasma glucose concentration and lipid profile in normal and streptozotocin-induced diabetic rats.
Sriplang K; Adisakwattana S; Rungsipipat A; Yibchok-Anun S
J Ethnopharmacol; 2007 Feb; 109(3):510-4. PubMed ID: 17034971
[TBL] [Abstract][Full Text] [Related]
19. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline.
Le Bihan G; Rondu F; Pelé-Tounian A; Wang X; Lidy S; Touboul E; Lamouri A; Dive G; Huet J; Pfeiffer B; Renard P; Guardiola-Lemaître B; Manéchez D; Pénicaud L; Ktorza A; Godfroid JJ
J Med Chem; 1999 May; 42(9):1587-603. PubMed ID: 10229628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
